StockData
Attovia Therapeutics, Inc. logo

Attovia Therapeutics, Inc. (ATTO) stock

ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$15.58+0.05 (+0.32%)

Close on Nov 19, 2026Market cap $711.25MP/E –Yield –

Attovia Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$25.02M–
Q2 FY2026Jun 30, 2026-$21.80M–
Q3 FY2025Sep 30, 2025-$15.60M–
Q2 FY2025Jun 30, 2025-$16.62M–

More Attovia Therapeutics figures

See a number that looks wrong?